Lisata Therapeutics Inc (LSTA)

Finanzdaten der Lisata Therapeutics Inc-Aktie (LSTA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-09-30	2025-06-30	2025-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	0.07	-
Operating Expenses	19.22%3.99	4.94	4.41	4.94	5.85
Depreciation and Amortization	50.00%0.00	0.00	0.04	0.04	0.04
Operating Income/Loss	19.22%-3.99	-4.94	-4.41	-4.87	-5.85
Nonoperating Income/Loss	1,511%1.06	0.07	0.17	0.21	0.16
Income/Loss From Continuing Operations Before Tax	39.93%-2.93	-4.88	-4.25	-4.66	-5.69
Income Tax Expense/Benefit	100.00%-	-0.39	-	-	-0.96
	34.75%-2.93	-4.49	-4.25	-4.66	-4.72
Attributable To Parent	34.75%-2.93	-4.49	-4.25	-4.66	-4.72
Basic Average Shares	1.11%9.11	9.01	8.74	8.61	8.60
Diluted Average Shares	1.11%9.11	9.01	8.74	8.61	8.60
Basic Earnings Per Share	36.00%-0.32	-0.50	-0.49	-0.54	-0.55
Diluted Earnings Per Share	36.00%-0.32	-0.50	-0.49	-0.54	-0.55